Gene Biotech Co., Ltd. (086060)
Market Closed
11 Aug, 06:30
KRX SM KRX SM Primary ₩
4,835. 00
-5
-0.1033%
₩
35.48B Market Cap
- P/E Ratio
120% Div Yield
28,664 Volume
- Eps
₩ 4,840
Previous Close Want to track 086060 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Gene Biotech Co., Ltd. (086060) Statistics
Valuation metrics
Market Cap 35.48B
Enterprise value 40.85B
Trailing P/E (ttm) 9.36
Forward P/E -
PEG ratio -0.36
Price/Sales (ttm) 0.39
Price/Book (mrq) 0.64
Enterprise Value/Revenue 0.45
Enterprise Value/EBITDA 6.41
Overview
Shares outstanding 8.61M
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 29.49K
Average volume (90 days) 35.28K
Price summary
52-Week low 3,525
52-Week high 5,990
Beta -
50-Day moving average 4,724.5
200-Day moving average 4,406.25
Dividends and splits
Forward annual dividend rate 120
Forward annual dividend yield 0.0291%
Trailing annual dividend rate 30
Trailing annual dividend yield 0.0073%
5-Year annual dividend yield -
Payout ratio -
Dividend Date 5 Jan 2022
Ex-Dividend Date 29 Dec 2021
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.16%
Operating margin 0.05%
Operational effectiveness
Return on assets 0.05%
Return on equity 0.07%
Income Statement
Revenue (ttm) 90.79B
Revenue per share (ttm) 10,543.45
Quarterly revenue growth (yoy) 0.05%
Gross profit (ttm) 14.39B
EBITDA 5.44B
Net income to common (ttm) 3.79B
Diluted EPS (ttm) 440
Quarterly earnings growth (yoy) 0.19%
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) -
Total debt (mrq) 16.43B
Total Debt/Equity (mrq) 0.3
Current ratio (mrq) 3.01%
Book value per share (mrq) 6,436.04
Cash Flow
Cash flow statement 7.4B
Levered free cash flow (LFCF) 3.79B
